AF
CTSO icon

Allworth Financial’s Cytosorbents Corp CTSO Stock Holding History

Allworth Financial’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-37
Closed -$56 – 3963
2024
Q3 		$56 Hold
37
– – ﹤0.01% 3683
2024
Q2 		$39 Hold
37
– – ﹤0.01% 3634
2024
Q1 		$36 Hold
37
– – ﹤0.01% 3543
2023
Q4 		$42 Hold
37
– – ﹤0.01% 3379
2023
Q3 		$70 Buy
+37
New +$106 ﹤0.01% 3360

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Allworth Financial's CTSO Position: Q4 2024 in Review

Allworth Financial sold out of Cytosorbents Corp (CTSO) in Q4 2024, closing a stake of 37 shares — an estimated $56 sold.

Allworth Financial first reported a position in CTSO in Q3 2023 and held it in 5 quarters. The position peaked at $70 in Q3 2023. 51 funds tracked by Wall St. Rank hold CTSO as of Q4 2024.

  • Allworth Financial reported no remaining Cytosorbents Corp position as of Q4 2024 after selling out during the quarter.
  • Allworth Financial sold 37 Cytosorbents Corp shares in Q4 2024, an estimated $56.
  • Allworth Financial first reported a position in Cytosorbents Corp in Q3 2023 and held it in 5 quarters.
  • Allworth Financial's Cytosorbents Corp position peaked at $70 in Q3 2023.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2024.

Based on Allworth Financial's 13F filing for Q4 2024, filed 30 Jan 2025.